David Ricol

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

David Cappellen, Catherine De Oliveira, David Ricol et al. · Nature Genetics · 1999 · 701 citations

Tumor Biology, Human Bladder, Urology +9

Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors

C Billerey, Dominique Chopin, Marie‐Hélène Aubriot‐Lorton et al. · American Journal Of Pathology · 2001 · 477 citations · Full text

Urology, Perineural Invasion, Genitourinary Cancer +5

Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b

Isabelle Bernard‐Pierrot, Aude Brams, Claire Dunois-Lardé et al. · Carcinogenesis · 2005 · 141 citations · Full text

Pathology, Cell Growth, Oncogenic Properties +17

Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer

David Ricol, David Cappellen, Ahmed El Marjou et al. · Oncogene · 1999 · 132 citations

Tumor Biology, Urology, Human Bladder Cancer +12

Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor

Isabelle Bernard‐Pierrot, David Ricol, Andrew Cassidy et al. · Oncogene · 2004 · 43 citations

Cancer Research, Urology, Genitourinary Cancer +9